Skip to main content
NeuronFeed
Imperagen

20+ Best Alternatives to Imperagen in 2026

Closed-loop, AI-guided enzyme engineering for improved and production-ready enzyme designs.

Looking for an alternative to Imperagen? Below are 20 AI startups working in the same space — ranked by our Neuron score so the most credible options come first. Each card shows what makes the tool a viable substitute, pricing signals, and funding stage.

  1. 1

    Isomorphic Labs

    $2.7B

    London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  2. 2

    Generate:Biomedicines

    $700M

    Generative AI for programmable protein therapeutics

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Custom

    View alternative →
  3. 3

    Proscia

    $130M

    AI-powered digital pathology for precision medicine

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Custom

    View alternative →
  4. 4

    Genesis Therapeutics

    $344M

    AI drug-discovery company building generative and predictive models to design small-molecule

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  5. 5

    Aqemia

    $103M

    French AI drug-discovery company that fuses quantum-inspired statistical mechanics with deep

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  6. 6

    Tahoe Therapeutics

    $30M

    Tahoe Therapeutics, formerly Vevo Therapeutics, builds gigascale single-cell datasets to train

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  7. 7

    Accipiter Biosciences

    $12.7M

    AI-designed de novo protein therapies for complex diseases

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Custom

    View alternative →
  8. 8

    Yoneda Labs

    $4M

    Foundation AI model for chemistry

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Custom

    View alternative →
  9. 9

    Recursion

    $500M

    Pioneering AI-driven solutions in drug discovery to radically improve lives.

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Enterprise · Contact sales

    View alternative →
  10. 10

    Alchemab Therapeutics

    $32M

    UK biotech using machine learning to mine patient-derived immune responses for protective

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  11. 11

    Paradigm Health

    $359M

    AI research platform making clinical trials part of routine patient care

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  12. 12

    Treeline Biosciences

    $1.1B

    Computational and experimental drug discovery for hard-to-drug cancer targets

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Enterprise · Contact sales

    View alternative →
  13. 13

    Ollin Biosciences

    $100M

    Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  14. 14

    Lindus Health

    $78M

    The anti-CRO running radically faster, AI-enabled clinical trials end to end

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  15. 15

    Edison Scientific

    $70M

    AI scientist that compresses months of research into a single day

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  16. 16

    Bioptimus

    $76M

    Building the first universal AI foundation model for biology.

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Enterprise · Contact sales

    View alternative →
  17. 17

    Ensocell

    $16.3M

    Cambridge, UK biotech that integrates single-cell and spatial genomics with AI to discover

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  18. 18

    Pathos AI

    $467M

    Patient-centric, AI-powered drug development company focused on accelerating cancer therapies

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Free

    View alternative →
  19. 19

    Genesis Molecular AI

    $280M

    Generative AI for small-molecule drug discovery

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Enterprise · Contact sales

    View alternative →
  20. 20

    Manas AI

    $24.6M

    AI-driven discovery of novel cancer medicines

    Why it's similar: Shares categories with Imperagen — Drug Discovery.

    💵 Enterprise · Contact sales

    View alternative →

Frequently asked questions

What are the best alternatives to Imperagen?

The top-ranked alternatives to Imperagen on NeuronFeed are Isomorphic Labs, Generate:Biomedicines, Proscia, Genesis Therapeutics, Aqemia. Rankings are based on our Neuron score, which weighs funding, momentum and editorial signal.

Is there a free alternative to Imperagen?

Yes — Isomorphic Labs, Genesis Therapeutics, Aqemia offer a free plans. See the pricing column for each alternative above.

How is this list ranked?

We rank alternatives by shared categories with Imperagen, then by our proprietary Neuron score (0–100) which combines funding, team quality, momentum, and editorial input. The list refreshes every 30 days.

Imperagen vs Isomorphic Labs — which is better?

It depends on use case. Isomorphic Labs (London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug) is the #1-ranked alternative. See the full side-by-side at /compare/imperagen-vs-isomorphic-labs.

Contextual paths to related AI startups, deals and rankings.